These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3390288)

  • 41. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Digital image analysis in cytological diagnosis: a morphometric analysis on pleural mesotheliomas.
    Christen H; Oberholzer M; Buser M; Lötscher R; Gschwind R; Rösel F; Ettlin R; Feess A; Dalquen P
    Anal Cell Pathol; 1989 Apr; 1(2):105-22. PubMed ID: 2487514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential diagnosis of malignant and reactive cells from serous effusions: image and texture analysis study.
    García-Bonafé M; Moragas A
    Anal Cell Pathol; 1996 Nov; 12(2):85-98. PubMed ID: 8986293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytomorphological features of metastatic squamous cell carcinoma in serous effusions.
    Huang CC; Michael CW
    Cytopathology; 2014 Apr; 25(2):112-9. PubMed ID: 23594308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
    Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A
    Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flow cytometric analysis of ploidy in immunohistochemically confirmed examples of malignant epithelial mesothelioma.
    Frierson HF; Mills SE; Legier JF
    Am J Clin Pathol; 1988 Sep; 90(3):240-3. PubMed ID: 3414598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet-derived growth factor receptor immunoreactivity in mesothelioma and nonneoplastic mesothelial cells in serous effusions.
    Ascoli V; Scalzo CC; Facciolo F; Nardi F
    Acta Cytol; 1995; 39(4):613-22. PubMed ID: 7543232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computerized interactive morphometry. A study of malignant mesothelioma and mesothelial hyperplasia in pleural biopsy specimens.
    Marchevsky AM; Gil J; Caccamo D
    Arch Pathol Lab Med; 1985 Dec; 109(12):1102-5. PubMed ID: 3840984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytologic re-evaluation of negative effusions from patients with malignant mesothelioma.
    Ascoli V; Bosco D; Carnovale Scalzo C
    Pathologica; 2011 Dec; 103(6):318-24. PubMed ID: 22558888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrastructural studies of cells in body cavity effusions.
    Bewtra C; Greer KP
    Acta Cytol; 1985; 29(3):226-38. PubMed ID: 3859122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biochemical and cytological features of diffuse mesotheliomas of the pleura.
    Matzel W
    Arch Geschwulstforsch; 1985; 55(4):259-64. PubMed ID: 4037997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An unusual cytologic presentation of mesothelioma in serous effusions.
    Spriggs AI; Grunze H
    Acta Cytol; 1983; 27(3):288-92. PubMed ID: 6575546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The malignancy grading method is not a reliable assessment of malignancy in mesothelioma.
    Tierney G; Wilkinson MJ; Jones JS
    J Pathol; 1990 Mar; 160(3):209-11. PubMed ID: 2335801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma.
    Davidson B; Skrede M; Silins I; Shih IeM; Trope CG; Flørenes VA
    Cancer; 2007 Sep; 110(6):1264-71. PubMed ID: 17647260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears.
    Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J
    Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.
    Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A
    Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A consideration on histopathologic variability of diffuse pleural mesothelioma based on DNA cytophotometry.
    Isoda K; Sobajima T; Kin H; Fukuda H; Hamamoto Y
    Acta Pathol Jpn; 1983 Jul; 33(4):807-16. PubMed ID: 6624456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flow cytometry and Feulgen cytophotometry in evaluation of effusions.
    Schneller J; Eppich E; Greenebaum E; Elequin F; Sherman A; Wersto R; Koss LG
    Cancer; 1987 Apr; 59(7):1307-13. PubMed ID: 2434207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polyploid mesothelial cells in pleural fluid.
    Isoda K; Hamamoto Y
    Acta Pathol Jpn; 1983 Jul; 33(4):733-8. PubMed ID: 6624453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesothelioma.
    Rao N; Wei S
    Cytojournal; 2022; 19():10. PubMed ID: 35510108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.